Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Dabai Xiaobai Technology is a specialized medical technology company focused on the research, development, and manufacturing of intelligent rehabilitation robots. The company primarily serves the neurorehabilitation market, providing advanced robotic solutions for patients recovering from stroke, spinal cord injuries, and other motor impairments. Their product suite includes AI-driven upper and lower limb rehabilitation systems designed to automate physical therapy and provide data-driven recovery tracking. Based in Wuhan's 'Optics Valley,' the company integrates robotics with clinical medicine to improve patient outcomes in hospitals and rehabilitation centers. Their mission is to alleviate the shortage of professional therapists through high-tech assistive devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Dabai Xiaobai Technology.